Analysis of the Frequency of level 1 OncoKB Genomic Alterations in Veterans With Various Solid Organ MalignanciesSeptember 4, 2025OncologyHepatocellular Carcinoma
HCC Updates: Quality Care Framework and Risk Stratification DataApril 16, 2025Hepatocellular CarcinomaOncology
Cancer Data Trends 2025April 16, 2025OncologyColorectal CancerLung CancerProstate CancerBreast CancerHepatocellular Carcinoma
Posterior Reversible Encephalopathy Syndrome (PRES) Following Bevacizumab and Atezolizumab Therapy in Hepatocellular Carcinoma (HCC)September 12, 2024OncologyHepatocellular Carcinoma
Cancer Data Trends 2024March 15, 2024CancerBreast CancerColon and RectalGenitourinary CancerHematologic MalignanciesHepatocellular CarcinomaLung Cancer
Drug combo improves recurrence-free survival after HCC resectionApril 27, 2023Hepatocellular Carcinoma
Commentary: Combination therapies and immunotherapy in HCC, December 2022November 29, 2022Hepatocellular Carcinoma
Microwave ablation: An alternative to resection in HCC with BCLC stage 0November 18, 2022Hepatocellular Carcinoma
Sequence of radiotherapy and TACE affects the prognosis of HCC with portal vein tumor thrombusNovember 18, 2022Hepatocellular Carcinoma
Atezolizumab+bevacizumab: A better first-line treatment option for unresectable HCC than lenvatinibNovember 18, 2022Hepatocellular Carcinoma
Alpha-fetoprotein and carbohydrate antigen 19-9: Prognostic markers in HCC after hepatectomyNovember 18, 2022Hepatocellular Carcinoma
HAIC+lenvatinib+sequential ablation: An effective and safe treatment option for advanced HCCNovember 18, 2022Hepatocellular Carcinoma
HCC: Atezolizumab+bevacizumab treatment outcome unaffected by the underlying liver etiologyNovember 18, 2022Hepatocellular Carcinoma
